Literature DB >> 22785192

A multilocus sequence typing scheme implies population structure and reveals several putative novel Achromobacter species.

Theodore Spilker1, Peter Vandamme, John J Lipuma.   

Abstract

The genus Achromobacter currently is comprised of seven species, including Achromobacter xylosoxidans, an opportunistic and nosocomial pathogen that displays broad-spectrum antimicrobial resistance and is recognized as causing chronic respiratory tract infection in persons with cystic fibrosis (CF). To enable strain typing for global epidemiologic investigations, to clarify the taxonomy of "Achromobacter-like" strains, and to elucidate the population structure of this genus, we developed a genus-level multilocus sequence typing (MLST) scheme. We employed in silico analyses of whole-genome sequences of several phylogenetically related genera, including Bordetella, Burkholderia, Cupriavidus, Herminiimonas, Janthinobacterium, Methylibium, and Ralstonia, for selecting loci and designing PCR primers. Using this MLST scheme, we analyzed 107 genetically diverse Achromobacter isolates cultured from biologic specimens from CF and non-CF patients, 1 isolate recovered from sludge, and an additional 39 strains obtained from culture collections. Sequence data from these 147 strains, plus three recently genome-sequenced Achromobacter strains, were assigned to 129 sequence types based on seven loci. Calculation of the nucleotide divergence of concatenated locus sequences within and between MLST clusters confirmed the seven previously named Achromobacter species and revealed 14 additional genogroups. Indices of association showed significant linkage disequilibrium in all of the species/genogroups able to be tested, indicating that each group has a clonal population structure. No clear segregation of species/genogroups between CF and non-CF sources was found.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22785192      PMCID: PMC3421806          DOI: 10.1128/JCM.00814-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Alcaligenes xylosoxidans endophthalmitis following phacoemulsification and intraocular lens implantation.

Authors:  Pierre-Yves Robert; Delphine Chainier; Fabien Garnier; Marie-Cécile Ploy; Pierre Parneix; Jean-Paul Adenis; Christian Martin
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2008 Nov-Dec

2.  A case of epidemic keratoconjunctivitis complicated by Alcaligenes xylosoxidans infection.

Authors:  Joo Youn Oh; Young Joo Shin; Won Ryang Wee
Journal:  Korean J Ophthalmol       Date:  2005-09

3.  Discovery and classification of ecological diversity in the bacterial world: the role of DNA sequence data.

Authors:  T Palys; L K Nakamura; F M Cohan
Journal:  Int J Syst Bacteriol       Date:  1997-10

4.  Chronic infection with Achromobacter xylosoxidans in cystic fibrosis patients; a retrospective case control study.

Authors:  Christine Rønne Hansen; Tacjana Pressler; Niels Høiby; Magdalena Gormsen
Journal:  J Cyst Fibros       Date:  2006-06-13       Impact factor: 5.482

Review 5.  The changing microbial epidemiology in cystic fibrosis.

Authors:  John J Lipuma
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

6.  Ribosomal DNA-directed PCR for identification of Achromobacter (Alcaligenes) xylosoxidans recovered from sputum samples from cystic fibrosis patients.

Authors:  Lixia Liu; Tom Coenye; Jane L Burns; Paul W Whitby; Terrence L Stull; John J LiPuma
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

7.  Achromobacter marplatensis sp. nov., isolated from a pentachlorophenol-contaminated soil.

Authors:  Margarita Gomila; Ludmila Tvrzová; Andrea Teshim; Ivo Sedláček; Narjol González-Escalona; Zbyněk Zdráhal; Ondrej Šedo; Jorge Froilán González; Antonio Bennasar; Edward R B Moore; Jorge Lalucat; Silvia E Murialdo
Journal:  Int J Syst Evol Microbiol       Date:  2010-10-15       Impact factor: 2.747

8.  Bacteremia caused by Achromobacter and Alcaligenes species in 46 patients with cancer (1989-2003).

Authors:  Gabriel Aisenberg; Kenneth V Rolston; Amar Safdar
Journal:  Cancer       Date:  2004-11-01       Impact factor: 6.860

9.  Why genes evolve faster on secondary chromosomes in bacteria.

Authors:  Vaughn S Cooper; Samuel H Vohr; Sarah C Wrocklage; Philip J Hatcher
Journal:  PLoS Comput Biol       Date:  2010-04-01       Impact factor: 4.475

10.  A Stenotrophomonas maltophilia multilocus sequence typing scheme for inferring population structure.

Authors:  Sabine Kaiser; Klaus Biehler; Daniel Jonas
Journal:  J Bacteriol       Date:  2009-02-27       Impact factor: 3.490

View more
  40 in total

1.  Chronic Airway Colonization by Achromobacter xylosoxidans in Cystic Fibrosis Patients Is Not Sustained by Their Domestic Environment.

Authors:  Chloé Dupont; Estelle Jumas-Bilak; Clara Doisy; Fabien Aujoulat; Raphaël Chiron; Hélène Marchandin
Journal:  Appl Environ Microbiol       Date:  2018-11-15       Impact factor: 4.792

2.  Prevalence and Outcomes of Achromobacter Species Infections in Adults with Cystic Fibrosis: a North American Cohort Study.

Authors:  B D Edwards; J Greysson-Wong; R Somayaji; B Waddell; F J Whelan; D G Storey; H R Rabin; M G Surette; M D Parkins
Journal:  J Clin Microbiol       Date:  2017-04-26       Impact factor: 5.948

3.  A simplified sequence-based identification scheme for Bordetella reveals several putative novel species.

Authors:  Theodore Spilker; Amy L Leber; Mario J Marcon; Duane W Newton; Rebecca Darrah; Peter Vandamme; John J Lipuma
Journal:  J Clin Microbiol       Date:  2013-12-11       Impact factor: 5.948

4.  Role of AxyZ Transcriptional Regulator in Overproduction of AxyXY-OprZ Multidrug Efflux System in Achromobacter Species Mutants Selected by Tobramycin.

Authors:  Julien Bador; Catherine Neuwirth; Nadège Grangier; Marie Muniz; Leslie Germé; Jérémy Bonnet; Vignesh-Guru Pillay; Catherine Llanes; Claire de Curraize; Lucie Amoureux
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

5.  Genomic insights into intrinsic and acquired drug resistance mechanisms in Achromobacter xylosoxidans.

Authors:  Yongfei Hu; Yuying Zhu; Yanan Ma; Fei Liu; Na Lu; Xi Yang; Chunguang Luan; Yong Yi; Baoli Zhu
Journal:  Antimicrob Agents Chemother       Date:  2014-12-08       Impact factor: 5.191

6.  Molecular characterization of Achromobacter isolates from cystic fibrosis and non-cystic fibrosis patients in Madrid, Spain.

Authors:  Laura Barrado; Patricia Brañas; M Ángeles Orellana; M Teresa Martínez; Gloria García; Joaquín R Otero; Fernando Chaves
Journal:  J Clin Microbiol       Date:  2013-03-27       Impact factor: 5.948

7.  Distribution of allelic variants of the chromosomal gene bla OXA-114-like in Achromobacter xylosoxidans clinical isolates.

Authors:  German Matías Traglia; Marisa Almuzara; Andrea Karina Merkier; Mariana Papalia; Laura Galanternik; Marcela Radice; Carlos Vay; Daniela Centrón; María Soledad Ramírez
Journal:  Curr Microbiol       Date:  2013-06-15       Impact factor: 2.188

8.  Characterization of Achromobacter Species in Cystic Fibrosis Patients: Comparison of bla(OXA-114) PCR Amplification, Multilocus Sequence Typing, and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry.

Authors:  Elenice R A Rodrigues; Alex G Ferreira; Robson S Leão; Cassiana C F Leite; Ana Paula Carvalho-Assef; Rodolpho M Albano; Elizabeth A Marques
Journal:  J Clin Microbiol       Date:  2015-12       Impact factor: 5.948

9.  Presence of OXA-type enzymes in Achromobacter insuavis and A. dolens.

Authors:  German Traglia; Mariana Papalia; Marisa Almuzara; Gabriel Gutkind; Daniela Centrón; Carlos Vay; Marcela Radice; María Soledad Ramírez
Journal:  Curr Microbiol       Date:  2014-06-04       Impact factor: 2.188

10.  Detection of Achromobacter xylosoxidans in hospital, domestic, and outdoor environmental samples and comparison with human clinical isolates.

Authors:  Lucie Amoureux; Julien Bador; Sakina Fardeheb; Cédric Mabille; Charlyne Couchot; Clémence Massip; Anne-Lise Salignon; Guillaume Berlie; Véronique Varin; Catherine Neuwirth
Journal:  Appl Environ Microbiol       Date:  2013-09-13       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.